Field Medical Manager, Northern Germany at Acadia Pharmaceuticals

Germany

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Pharmaceutical, Rare DiseasesIndustries

Requirements

  • Advanced degree in science or clinical (e.g. MD, Pharm.D., PhD)
  • Minimum of 3 years of experience as a Medical Science Liaison, Medical Advisor, or comparable role
  • Previous experience in rare diseases and/or in hepatology or gastroenterology strongly preferred
  • Strong ability to interpret, analyze, and communicate complex scientific information effectively
  • Excellent written and verbal communication skills in English and German
  • High level of business acumen and organizational skills
  • Proven presentation skills across different audiences and settings
  • Advanced proficiency in MS Office (Word, Excel, PowerPoint) and willingness to learn new systems
  • Willingness to travel up to [specified amount]

Responsibilities

  • Identifies, can gain access to, and develops professional relationships with thought leaders and other healthcare professionals, active and potential study investigators, and professional organizations within their assigned geography
  • Develop, plan, implement and execute local medical affairs projects, including but not limited to regional advisory boards, medical education projects, regional symposia, patient support projects and publications
  • Support the local adaptation and implementation of International (EU) and/or global medical affairs projects in his Country
  • Supports research initiatives across development and provides support to clinical site investigators
  • Serves as a liaison between HCPs who express interest in conducting investigator-initiated research to facilitate review and consideration of research proposals
  • Engages in scientific exchange in response to thought leader requests
  • Can effectively articulate relevant scientific and clinical information relative to the therapeutic area to HCPs and researchers
  • Utilizes scientific resources to deliver impactful presentations to varying audiences and in a variety of different settings including (but not limited to) advisory boards, patient advocacy groups, and payors
  • Identifies and proactively communicates research gaps, opportunities, and relevant field intelligence to senior management to help forming medical strategy
  • Supports company-sponsored research, investigator-initiated research, and publications
  • Supports the cross-functional team by providing onboarding and continued medical training to commercial colleagues and newly hired medical colleagues
  • Stays abreast of emerging scientific literature and clinical data
  • Attends medical/scientific meetings and congresses to represent Medical Affairs, strengthen individual expertise as well as capture, integrate, and summarize information of strategic interest
  • Actively participates in internal medical affairs team meetings to contribute into the building and development of a strong and aligned global medical affairs function
  • Fully compliant with all company SOPs, regulatory requirements, and applicable laws including codices for field-based employees
  • Completes other responsibilities in a timely manner, as assigned

Skills

KOL Engagement
Medical Affairs
Scientific Exchange
Project Management
Advisory Boards
Medical Education
Investigator Support
Clinical Research
HCP Relationships
Rare Diseases

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI